Publications
2 shownTrastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
In this trial involving patients with HER2-low metastatic breast cancer, trastuzumab deruxtecan resulted in significantly longer progression-free and overall survival than the p...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 14,061
- Institution
- University of North Carolina at Chapel Hill
External Links
Identifiers
- ORCID
- 0000-0003-2377-540X
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.